65 Therapeutics, Inc. — Form D
65 Therapeutics, Inc. of SOMERVILLE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-06. The offering totals $5.5M, of which $4.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-12-06
- Form: D
- Accession: 0002047647-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $4.5M
- Remaining: $1.0M
- Investors: 2
- Date of first sale: 2024-11-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-531309
Issuer
- Name: 65 Therapeutics, Inc.
- CIK: 0002047647
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 399 REVOLUTION DRIVE 399 Revolution Drive, SOMERVILLE, MA, 02145
- Phone: 617-784-9147
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Murthy Chavali | Director | Somerville, MA |
| Julius Knowles | Director | Somerville, MA |
| Julius Knowles | Executive Officer | Somerville, MA |
| Murthy Chavali | Related Person | Somerville, MA |
| Julius Knowles | Related Person | Somerville, MA |
Other filings by this issuer (1)
More